Three More Drugs Have Been Added to the SGK Reimbursement List.
11 Articles
11 Articles
Minister of Labor and Social Security Vedat Işıkhan announced that two more Hemophilia B drugs and one cancer drug have been added to the Social Security Institution's (SGK) reimbursement list. The amount paid by SGK for magistral medicines produced in pharmacies has also been increased by 40 percent.
Cumhuriyet
Minister of Labor and Social Security Vedat Işıkhan announced that 2 Hemophilia B drugs and 1 cancer drug have been added to the Social Security Institution's reimbursement list.
Minister of Labor and Social Security Vedat Işıkhan announced that two more Hemophilia B drugs and one cancer drug have been added to the Social Security Institution's (SGK) reimbursement list. Minister Işıkhan shared this information on his NSosyal social media account, citing the 'Social Security Institution Health Application...' published in the Official Gazette.
Economy - Minister Işıkhan announced that 2 more Hemophilia B drugs (one of which is domestically produced) and 1 cancer drug have been added to the Social Security Institution's reimbursement list.
Three new drugs have been added to the Social Security Institution's (SGK) reimbursement list: two Hemophilia B drugs and one cancer drug. Minister of Labor and Social Security Vedat Işıkhan also announced that the amount paid by SGK for magistral preparations in pharmacies has been increased by 40 percent.
Minister of Labor and Social Security Vedat Işıkhan announced that two more Hemophilia B drugs (one of which is domestically produced) and one cancer drug have been added to the Social Security Institution's reimbursement list. Additionally, the reimbursement amount for magistral preparations in pharmacies has been increased by 40%; and critical improvements have been made to bone marrow transplantation processes.
Coverage Details
Bias Distribution
- 67% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
